Literature DB >> 170337

Studies on the adjuvant effect of Bordetella pertussis vaccine to sheep erythrocytes in the mouse. I. In vitro enhancement of antibody formation with normal spleen cells.

A J Murgo, T J Athanassiades.   

Abstract

The adjuvant effect of Bordetella pertussis vaccine (PV) on the antibody response to sheep erythrocytes (SRBC) has been studied in vitro with the Mishell-Dutton immunization technique. The addition of PV to cultures of spleen cells obtained from normal non-immunized mice markedly enhanced the plaque-forming cell response to SRBC. The greatest enhancement was evident at 24 hr of culture. PV was also shown to enhance the antibody response of spleen cells that had been depleted of either T lymphocytes or adherent cells, presumably macrophages. In addition, it was found that PV, per se, released into the culture medium a soluble cell-free component(s) that contributed significantly to adjuvanticity. The results suggest that at least one of the ways that PV enhances the in vitro immune response to SRBC is by direct stimulation of precursors of antibody-forming cells.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 170337

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

Review 1.  Immunocompetent cells in resistance to bacterial infections.

Authors:  P A Campbell
Journal:  Bacteriol Rev       Date:  1976-06

2.  Adjuvant effect of Bordetella pertussis vaccine to sheep erythrocytes in mice: enhancement of cell-mediated immunity by subcutaneous administration of adjuvant and antigen.

Authors:  T J Athanassiades
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

3.  The adjuvant effect of Corynebacterium parvum: T-cell dependence of macrophage activation.

Authors:  V S Sljivić; S R Watson
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

4.  Cellular events in the induction of experimental allergic encephalomyelitis in rats.

Authors:  L Ortiz-Ortiz; W O Weigle
Journal:  J Exp Med       Date:  1976-09-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.